Blog Posts - Malignant Mesothelioma

Medical Research Development: EPHB2 Found To Be Significantly Elevated In Malignant Pleural Mesothelioma Tumors According To September 2013 Journal of Thoracic Oncology Article

The International Association for the Study of Lung Cancer (IASLC) is making people aware of a recent medical research development that may have benefits as regards possible new treatments for malignant pleural mesothelioma. From this article, “...
by AsbestosHUB on Sep 10, 2013

New Medical Journal Article Presents Two Case Reports Involving Pericardial Mesothelioma And Suggests This Type Of Malignant Mesothelioma Is Not Always Related To Asbestos Exposure

From a summer 2013 edition of Case Reports in Oncological Medicine we get an interesting article about two patients diagnosed with pericardial malignant mesothelioma. The first case involved a 57-year old man with a two-month history of dyspnea on ex...
by AsbestosHUB on Sep 3, 2013

The Function of Your Illinois Mesothelioma lawyer

Undergoing healthcare therapy is essential following a diagnosis of mesothelioma. A skilled, licensed doctor can... more »...
by Affiliate Mistakes on Aug 19, 2013

FDA Allows Experimental Cancer Drug VS-6063 To Move Forward And Possibly Be New Mesothelioma Treatment In U.S.

In early July 2013 we wrote this article, “Investigational Mesothelioma Treatment VS-6063 From Verastem Granted Orphan-Drug Status In European Union”, which gave us hope there might be a new treatment for mesothelioma.  The problem was,...
by AsbestosHUB on Aug 9, 2013

North Carolina Bankruptcy Trial: Garlock Says Its Will Pay Only $270 Million While Attorneys For Asbestos Disease Victims Say Company Owes $1.3 Billion On Current And Future Asbestos Claims

Last month we posted our initial report about the Garlock bankruptcy trial, July 2013 Garlock Estimation Trial In North Carolina: Ruling By Bankruptcy Judge George Hodges Rejects Company’s Attempt To Reveal Confidential Claims Information From Oth...
by AsbestosHUB on Aug 5, 2013

Investigational Mesothelioma Treatment VS-6063 From Verastem Granted Orphan-Drug Status In European Union

As reported online June 13, 2013 by the Wall Street Journal, “Verastem Investigational Mesothelioma Treatment Gets Orphan Status in EU”: Verastem Inc. (VSTM) was granted orphan status by European regulators for its investigational treatme...
by AsbestosHUB on Jul 5, 2013

Experimental Mesothelioma Treatment Drug Shows Promise For Slowing Disease Progression In Some Patients

In November 2012 the Science Codex web site posted this article of interest, “Mesothelioma drug slows disease progression in patients with an inactive NF2 gene”. This article is significant because it reported that preliminary findings fr...
by AsbestosHUB on Jun 28, 2013

Medical Study Shows Factors That May Negatively Affect Pleural Mesothelioma Survival Time Include Older Age, Histologic Type, And Leukocytosis

In 2013 The Journal of Thoracic and Cardiovascular Surgery published an article “Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis” which identified some factors that may influence the av...
by AsbestosHUB on Jun 24, 2013

The Important to Creating Your Self-Esteem

Self-esteem is a state of mind. It can fill you with happiness, cheer, and self-assurance. It can also make you feel terrible about oneself. Self-esteem is like a battery. When the battery is charged, the individual is good when the battery is low, t...
by Article Technology on May 8, 2013

Trending Topics